Cleveland Clinic Thyroid Expo
The Cleveland Clinic Thyroid Expo provides an updated review of the many multidisciplinary guidelines for the treatment of thyroid disorders. An expert faculty addresses topics such as molecular applications in thyroid neoplasia, cancer care, practical management tips and advances in laboratory testing. It focuses on new technologies in thyroid surgery, with a goal of increasing competence and clinical performance in managing routine and complex patient cases.
Worth 5 AMA PRA Category I Credits™, this activity is essential for all physicians, nurses and physician assistants involved in the care of patients with thyroid disease, including those in primary care, endocrinology, surgery, pathology, genetics, immunology and oncology. ANCC and AAPA accreditation also provided with NO POST TEST. Additionally, physicians can earn up to 5 points for ABIM MOC and ABS continuous certification.
Cost: $99.00Add to cart
Key Features
Multidisciplinary update on the treatment of thyroid disorders. 5 AMA PRA Category I Credits™ and ABIM MOC.
Topics Covered
Thyroid nodules, neoplasms and cytopathology, thyroid cancer management and therapy, thyroid eye disease, surgical technologies, case discussions and much more!
Learning Objectives
Upon completion of this activity, the participant will be able to:
Summarize the updated ATA guidelines for classification, risk stratification, management and indications for fine needle aspiration of thyroid nodules, and interpret their clinical practice implications.
Recognize the key updates for thyroid cytology and thyroid neoplasm classification, and describe their clinical practice implications.
Distinguish the state-of-the-art laboratory tests for thyroid disease, including immunoassays and mass spectrometry, list their analytical limitations and discuss their role in evaluating thyroid disease.
Critically review the efficacy, side effects and clinical indications for thyroid cancer therapies, both FDA-approved and those in development.
Summarize the efficacy and safety profiles of targeted therapies for thyroid cancer and describe current research in targeted drug development and combination therapies.
Identify the molecular signatures associated with specific thyroid malignancies.
Describe the pathophysiology of thyroid eye disease and recognize the role of endocrinologists in its assessment, diagnosis and medical management.
Recognize the different surgical options and modalities in the treatment of patients with various types of thyroid disorders and stages of thyroid cancer.
Target Audience
The course is designed for a multidisciplinary audience. Physicians, PAs, nurses, residents, fellows and other health care professionals in primary care as well as other specialties such as endocrinology, surgery, pathology, genetics, immunology and oncology can benefit from this activity.
Additional credit info
Release date: June 10, 2024
CME Expiration: June 9, 2026